The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Boston. Gilgeous-Alexander then threw a lob pass to Isaiah Hartenstein for a dunk that shook the building and the vibration was also felt at the very top of the MVP ladder. By all accounts ...

Commissions do not affect our editors' opinions or evaluations. Ladder offers the convenience of no-exam term life insurance for those looking for $3 million or less in coverage. The application ...

Credit: Kim Kuperkova / Shutterstock. Taiwanese pharmaceutical company Xgene Pharmaceutical announced that its non-opioid analgesic drug XG005 has reduced acute pain in patients after surgery in a ...

We just don't know who the Joker is. As Claudio Castagnoli, Dante Martin and Wheeler Yuta were on the ladder, a group of masked men came out and cleared the ring. Another masked man climbed the ladder ...